Cargando…
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283549/ https://www.ncbi.nlm.nih.gov/pubmed/30521628 http://dx.doi.org/10.1371/journal.pone.0209108 |
_version_ | 1783379180083216384 |
---|---|
author | Lange, Andrzej Jaskula, Emilia Lange, Janusz Dworacki, Grzegorz Nowak, Dorota Simiczyjew, Aleksandra Mordak-Domagala, Monika Sedzimirska, Mariola |
author_facet | Lange, Andrzej Jaskula, Emilia Lange, Janusz Dworacki, Grzegorz Nowak, Dorota Simiczyjew, Aleksandra Mordak-Domagala, Monika Sedzimirska, Mariola |
author_sort | Lange, Andrzej |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6283549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-62835492018-12-20 Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow Lange, Andrzej Jaskula, Emilia Lange, Janusz Dworacki, Grzegorz Nowak, Dorota Simiczyjew, Aleksandra Mordak-Domagala, Monika Sedzimirska, Mariola PLoS One Correction Public Library of Science 2018-12-06 /pmc/articles/PMC6283549/ /pubmed/30521628 http://dx.doi.org/10.1371/journal.pone.0209108 Text en © 2018 Lange et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Lange, Andrzej Jaskula, Emilia Lange, Janusz Dworacki, Grzegorz Nowak, Dorota Simiczyjew, Aleksandra Mordak-Domagala, Monika Sedzimirska, Mariola Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow |
title | Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow |
title_full | Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow |
title_fullStr | Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow |
title_full_unstemmed | Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow |
title_short | Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow |
title_sort | correction: the sorafenib anti-relapse effect after allohsct is associated with heightened alloreactivity and accumulation of cd8+pd-1+ (cd279+) lymphocytes in marrow |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283549/ https://www.ncbi.nlm.nih.gov/pubmed/30521628 http://dx.doi.org/10.1371/journal.pone.0209108 |
work_keys_str_mv | AT langeandrzej correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT jaskulaemilia correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT langejanusz correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT dworackigrzegorz correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT nowakdorota correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT simiczyjewaleksandra correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT mordakdomagalamonika correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow AT sedzimirskamariola correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow |